| |
original article |
Date |
Title |
Authors All Authors |
| 1 |
[GO] |
2025―Jul―21 |
Computational Investigation of Natural Substances as SARS-CoV-2 Main Protease Inhibitors: A Virtual Screening Method |
Deepak K. Lokwani, Sangita R. Chavan, Shirish P. Jain, Samiksha R. Shengokar, Titiksh L. Devale |
| 2 |
[GO] |
2025―May―16 |
Use of any form of Amphotericin B Alone or with Posaconazole in COVID-19 Associated Mucormycosis (CAM) at the Time of Pandemic Disaster in a Tertiary Care Teaching Hospital |
Pugazhenthan Thangaraju, Ripudaman Arora, Nitin M. Nagarkar, Pankaj Kumar Kannauje, Rupa Mehta, Hemasri Velmurugan, Muthathal Subramanian |
| 3 |
[GO] |
2023―Sep―15 |
The efficacy of colchicine as an adjunct therapy in non-hospitalized COVID-19 patients: A randomized placebo-controlled trial |
Sepideh Hejazi, Zohreh Jahani, Sepideh Elyasi, Davoud Salarbashi, Mona Kabiri |
| 4 |
[GO] |
2023―Mar―31 |
Outpatient Intravenous Remdesivir to Prevent Progression to Severe COVID-19:
An Observational Study from a Greek Hospital |
Nikolaos Kintrilis, Iosif Galinos |
| 5 |
[GO] |
2023―Mar―31 |
Covid-19 Study, Diagnostic and Therapeutic Transition |
Da Yong Lu, Ting Ren Lu |
| 6 |
[GO] |
2023―Feb―23 |
Effect of TeleYoga before COVID-19 and during pandemic: A Narrative Review |
Dua R, Malik S, Kumar R, Sharma I, Kumar S, Mirza AA, Sindhwani G |
| 7 |
[GO] |
2023―Feb―23 |
Effects of Active Compounds of Nigella sativa in COVID-19: A Narrative Review |
Mirza AA, Usmani H, Malik S, Arya A, Mahto PK, Kant R, et al. (+3) Dua R, Sindhwani D, P.K. Panda |
| 8 |
[GO] |
2023―Jan―19 |
SARS CoV2 pandemic - Therapeutics in Warp Speed |
Sourav Sen, Nitin Kumar |
| 9 |
[GO] |
2022―Nov―11 |
COVID-19: An Update |
Prasan Kumar Panda |
| 10 |
[GO] |
2022―Oct―12 |
COVID-19 Infection after vaccination among Healthcare Workers at a Tertiary Level Health Care Center in Northern India: A Cross-Sectional Study |
Mahendra Singh, Nandita Sharma, Pradeep Aggarwal, Yogesh Bahurupi, P. K. Panda, Gaurika Saxena |
| 11 |
[GO] |
2022―Sep―09 |
Triggers for Acceptance of COVID-19 Vaccination: A Community-Based Study |
Mohammed A. Medhat, Mohamed O. Nour, Ahmed Yousef, Fathiya El-Raey, Heba Aly, Sherief Mousa, et al. (+9) Nahed A Makhlouf, Mohamed Elbadry, Amin Abdel Baki, Maysaa A. Saeed, Sherief Abd-Elsalam, Esssam A. Hassan, Shaker Wagih Shaltout, Hanaa Kh.Fathelbab, Samy Zaky |
| 12 |
[GO] |
2022―Sep―03 |
Atorvastatin efficacy in the management of mild to moderate hospitalized COVID-19: a pilot randomized triple-blind placebo-controlled clinical trial |
Farzam Mircheraghi, Najmeh Davoodian, Sepideh Hejazi, Sepideh Elyasi, Davoud Salarbashi, Hasan Mahrad Majd |
| 13 |
[GO] |
2022―Aug―18 |
Whether Early Steroid dose is associated with lower mortality in COVID-19 critically ill Patients- An exploratory chart review |
Abhishek Goyal, Ankur Joshi, Saurabh Saigal, Dodda Brahmam, Yogesh Niwariya, Alkesh Khurana, et al. (+2) Sagar Khadanga, Arun Mitra |
| 14 |
[GO] |
2022―Jul―22 |
Clinical profile, risk factors, and therapeutic outcome of cavitating fungal pneumonia coinfection in COVID-19 patients: A retrospective analysis |
Arjun Kumar, Mayank Mishra, Saikat Banerjee, Lokesh Kumar Saini, Prakhar Sharma, Ruchi Dua, Girish Sindhwani |
| 15 |
[GO] |
2022―Jul―04 |
Utility of walk tests in progression of mild COVID-19 infection at a tertiary hospital in North India |
Souradeep Chowdhury, Tamoghna Ghosh, Aastha Goel, Anupam K Singh, Arvind Kumar, Naveet Wig |
| 16 |
[GO] |
2022―May―20 |
Mapping of new pharmacological alternatives in the face of the emergence of antibiotic resistance in COVID-19 patents treated for opportunistic respiratory bacterial pathogens |
Anamaria Mendonça Santos, Mariana Mendonça Santos, José Adão Carvalho Nascimento Júnior, João Rafael Lisboa Rêgo Brito, Tatianny de Araújo Andrade, Luiza Abrahão Frank, Mairim Russo Serafini |
| 17 |
[GO] |
2021―Nov―25 |
The newfangled upsurge of Double mutant SARS-CoV-2 virus in a 2021-Current scenario and inspecting ahead |
Sukhes Mukherjee, Suman Kumar Ray |
| 18 |
[GO] |
2021―Nov―23 |
The spectrum of biochemical alterations with molecular and serological biomarkers in the diagnosis of COVID-19: searching for novel one to identify disease earlier with better prognosis and drug discovery |
Suman Kumar Ray, Sukhes Mukherjee |
| 19 |
[GO] |
2021―Jun―17 |
Taming the storm in the heart: exploring different therapeutic choices against myocardial inflammation in COVID-19 |
Abhigyan Choudhury, Suprabhat Mukherjee |
